WSJ Minute Briefing - Customer Cancellations for Disney+ and Hulu Rose Following Kimmel Suspension

Plus: U.S. officials head to Israel in an attempt to shore up the fragile cease-fire in Gaza. And Molson Coors eliminates roughly 400 positions in a restructuring effort. Zoe Kuhlkin hosts.


Sign up for WSJ’s free What’s News newsletter.


An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ What’s News - Apps, Websites Hit by Major Outage at Amazon Web Services

A.M. Edition for Oct. 20. Facebook, Snapchat and Robinhood are just a few of the hundreds of companies affected by the outage overnight. Trump vows to halt U.S. aid to Colombia, as the president turns up the heat on Latin America. And, U.S. stocks might be close to all time highs, but Rebecca Feng says warning signs are flashing just below the surface. Caitlin McCabe Hosts hosts.


Sign up for the WSJ’s free What’s News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ What’s News - An Economy Built on Speculation—for Better and for Worse

From the land mania following the Revolutionary War to the AI craze now, speculation is in the American economy's DNA. These kinds of big bets have shaped our present and continue to fuel tomorrow's economic growth. Host Katherine Sullivan unpacks the past and future of American speculators. This episode is part of The Wall Street Journal’s USA250: The Story of the World’s Greatest Economy, a collection of articles, videos and podcasts aiming to offer a deeper understanding of how America has evolved.


Further Reading:

From Sports to AI, America Is Awash in Speculative Fever. Washington Is Egging It On.

Capitalism and Democracy Often Clash in America. They Usually End Up Better for It.

Financial Bubbles Happen Less Often Than You Think

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ What’s News - What’s News in Markets: AI Deals, Trump on Pharma, Banks Split

How did the week’s AI dealmaking affect stocks? And why did President Trump’s comments on weight-loss drugs hurt pharma shares? Plus, how did the big six U.S. banks finish out the week after strong quarterly reports? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.


Sign up for the WSJ's free Markets A.M. newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ Your Money Briefing - What’s News in Markets: AI Deals, Trump on Pharma, Banks Split

How did the week’s AI dealmaking affect stocks? And why did President Trump’s comments on weight-loss drugs hurt pharma shares? Plus, how did the big six U.S. banks finish out the week after strong quarterly reports? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.


Sign up for the WSJ's free Markets A.M. newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ What’s News - The Trump Administration Is Quietly Watering Down Some Tariffs

P.M. Edition for Oct. 17. In recent weeks, President Trump has been tiptoeing away from some of the tariffs that underpin his signature trade policy, saying reciprocal tariffs don’t apply to dozens of different products. We hear from WSJ trade and economic policy reporter Gavin Bade about why that’s happening. Plus, a decade ago, Walmart rattled investors with a historic pay raise for employees to $9 an hour. WSJ reporter Sarah Nassauer tells us why today the move is considered a success. Plus, in a meeting with Ukrainian President Volodymyr Zelensky at the White House today, President Trump said he’d rather end the war in Ukraine than send Tomahawks to the country. Alex Ossola hosts.


Sign up for the WSJ's free What's News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ Minute Briefing - Stocks Inch Up as China Trade Tensions Ease

Plus: American Express posted higher than expected gains. And Novo Nordisk shares drop after President Trump suggests a lower price for its weight loss drug. Katherine Sullivan hosts.


Sign up for the WSJ's free What's News newsletter.


An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Learn more about your ad choices. Visit megaphone.fm/adchoices